DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE and CONDITION AGGRAVATED

1 reports of this reaction

25.0% of all DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE reports

#1 most reported adverse reaction

Overview

CONDITION AGGRAVATED is the #1 most commonly reported adverse reaction for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, manufactured by Ajanta Pharma USA Inc.. There are 1 FDA adverse event reports linking DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE to CONDITION AGGRAVATED. This represents approximately 25.0% of all 4 adverse event reports for this drug.

Patients taking DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE who experience condition aggravated should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CONDITION AGGRAVATED1 of 4 reports

CONDITION AGGRAVATED is a frequently reported adverse event for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, accounting for a significant proportion of all reports.

Other Side Effects of DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE

In addition to condition aggravated, the following adverse reactions have been reported for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE:

Other Drugs Associated with CONDITION AGGRAVATED

The following drugs have also been linked to condition aggravated in FDA adverse event reports:

ABATACEPTACETAMINOPHEN 500MGACETAMINOPHEN TABLET EXTENDED RELEASEACETAZOLAMIDEACETYLCYSTEINEACTIVATED CHARCOALADALIMUMAB AATYADALIMUMAB ADAZADALIMUMAB FKJPADAPALENEADAPALENE AND BENZOYL PEROXIDEAGALSIDASE BETAALBENDAZOLEALBUTEROLALEMTUZUMABALENDRONATE SODIUM TABLETALLANTOINALLOPURINOL SODIUM.ALPHA. TOCOPHEROL ACETATE, DL , ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN DALUMINUM CHLORIDE

Frequently Asked Questions

Does DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE cause CONDITION AGGRAVATED?

CONDITION AGGRAVATED has been reported as an adverse event in 1 FDA reports for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CONDITION AGGRAVATED with DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE?

CONDITION AGGRAVATED accounts for approximately 25.0% of all adverse event reports for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, making it one of the most commonly reported side effect.

What should I do if I experience CONDITION AGGRAVATED while taking DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE?

If you experience condition aggravated while taking DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE Full ProfileAll Drugs Causing CONDITION AGGRAVATEDAjanta Pharma USA Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.